openPR Logo
Press release

The Oral Solid Dosage Contract Manufacturing Market to Stay Steadfast On Wearables

02-11-2022 03:15 AM CET | Health & Medicine

Press release from: Persistence Market Research

The Oral Solid Dosage Contract Manufacturing Market to Stay

The Oral Solid Dosage Contract Manufacturing Market is bound to grow robustly in the years to come. With smart technology and 5G being increasingly adopted, the healthcare vertical is witnessing a paradigm shift. These technologies can thus increase the convenience quotient (CQ), as abysmal disruption happens in the patients’ lives. This convenience quotient would be the trend running in the healthcare vertical shortly.

The existing biologics-development pipeline supports an outlook of continued strong growth for contract manufacturing. Annually, the number of biotech patents applied for has been mounting at approximately 23 percent. There are currently more than 1,500 biomolecules undergoing clinical trials, which are targeting more than 100 hundred types of diseases; the success rate for biologics has so far been over twice that of small-molecule products.

Pharmaceutical contract manufacturing plays an important role in commercial manufacturing as well as late clinical phase of solid dosage drug production. Big pharma companies have limited capacity for biopharmaceutical production due to high operating and production costs, and this leads to the outsourcing of pharmaceutical drug production through contract manufacturing.

Get Sample Copy of this Reporthttps://www.persistencemarketresearch.com/samples/25768

The COVID-19 pandemic has affected the market quiet significantly. Lockdowns in the first half of 2020 led to shortage of human resources, thereby slowing down oral solid dosage contract manufacturing. In addition, it also led to severe disruption in the supply chain of raw material, which further led to interrupted development activities. The pandemic also resulted a large number of pharmaceutical companies channeling their major focus on the development of COVID-19 products. However, with rapid changes in the business models adopted by contract manufacturing companies, and with the improving situations as a result of the introduction of vaccines, the future looks bright.

The global oral solid dosage contract manufacturing market is estimated to be valued at around US$ 21 Bn in 2020, with the market expected to exhibit a CAGR of close to 6% over the forecast period (2020-2030).

Company Profiles:

AbbVie Inc.
Thermo Fisher Scientific Inc. (Patheon N.V.)
Lonza
Catalent Inc.
Alcami Corporation
Halo Pharmaceutical Inc.
CordenPharma International
Arnet Pharmaceuticals
Jubilant Life Sciences
Pfizer Inc.
Piramal EnterprisesLtd
Metrics Contract Services
GENVION Corporation
GlaxoSmithKline plc.
CMIC HOLDINGS Co., LTD.
Tower Laboratories Ltd.
PNP Pharmaceuticals Inc.
Confab Laboratories Inc.
Wockhardt Ltd.
Pharma Tech Industries

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25768

Key Takeaways from Study

By product, tablets dominated with a market share of almost 55%, and will further observe a rise in market share during the forecast period, due to increasing usage of tablets as compared to other forms.
Under release mechanism, again tablets will dominate the market, contributing for more than half of the revenue share.
The market in India and China is growing at a significantly high rate (around 7% CAGR), due to rising number of contract manufacturing organizations and low manufacturing costs in these countries. Thus, it can be concluded that, these markets will represent highly lucrative growth opportunities during the forecast period.
Pharma /biotech companies, both big and small. Will hold bulk of the market share through 2030, at around three-fourth share.

“Increasing adoption of CDMO and CMO business models in terms of product offerings, and reduction in operational costs, are expected to surge demand for oral solid dosage contract manufacturing,” says a Persistence Market research analyst.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25768

Oral Solid Dosage Contract Manufacturers Aiming to Fortify their Position through Acquisitions

Key market leaders of pharmaceutical solid dosage contract manufacturing are constantly focusing on industrial developmental activities such as acquisition of small- and mid-sized companies to expand their service portfolios, which will accelerate market growth. Growing preference for contract manufacturing of pharmaceutical products is attracting market leaders to expand their manufacturing capacities through strategic acquisition of small companies. In order to meet the drug manufacturing needs of global biotech, pharmaceutical, and generic drug customers, contract manufacturers are focusing on expansion of their industrial and commercial platforms through acquisitions.

For instance, in September 2018, Cambrex Corporation acquired a leading contract development and manufacturing organization (CDMO) Halo Pharma (Halo), located in New Jersey, U.S., and Canada, to expand its contract manufacturing services.

Key Participant Insights

The global oral solid dosage contract manufacturing market is set to expand its scope during the forecast period due to strong biologics pipeline, increasing activities by key players, and rise in adoption of CDMO and CMO business models. The market is expected to grow exponentially, especially in Asia, with India and China representing maximum growth potential.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/oral-solid-dosage-contract-manufacturing-market.asp

Want more insights?

Persistence Market Research brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global oral solid dosage contract manufacturing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provide compelling insights on the basis of product (tablets, capsules, and powders & granules), release mechanism (tablets, capsules, and powder & granules), and end user (big pharma or biotech, small & medium size pharma or biotech, emerging or virtual pharma, and nutraceutical companies), across seven major regions of the world.

Related Reports:

North America Toxicology Laboratories Market - https://www.persistencemarketresearch.com/market-research/north-america-toxicology-laboratories-market.asp

Delivery Systems In Personal Care Market - https://www.persistencemarketresearch.com/market-research/delivery-systems-in-personal-care-market.asp

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Oral Solid Dosage Contract Manufacturing Market to Stay Steadfast On Wearables here

News-ID: 2550075 • Views:

More Releases from Persistence Market Research

High Speed Steel (HSS) Metal Cutting Tools Market Innovations, Precision Engineering, and Emerging Trends Driving Industrial Machining
High Speed Steel (HSS) Metal Cutting Tools Market Innovations, Precision Enginee …
The High Speed Steel (HSS) metal cutting tools market is witnessing significant growth due to the increasing demand for efficient, precise, and durable machining solutions across diverse industries. HSS tools, renowned for their exceptional hardness, heat resistance, and versatility, are widely used in metal cutting applications including drilling, milling, turning, and threading. The global high speed steel (HSS) metal cutting tools market size is likely to be valued at US$
Medical Automation Market Expands as AI, Robotics, and IoT Drive Smarter Healthcare Systems
Medical Automation Market Expands as AI, Robotics, and IoT Drive Smarter Healthc …
The global medical automation market is poised for significant growth over the next decade, with projections indicating an expansion from US$48.7 billion in 2023 to US$84 billion by 2030, representing a robust compound annual growth rate (CAGR) of 8.1%. This growth trajectory reflects the increasing adoption of advanced automation technologies across healthcare facilities worldwide, driven by the rising demand for operational efficiency, precision in diagnostics, and enhanced patient care. Get a
Industrial X-ray Inspection Systems Market Advanced Imaging, Automation, and Emerging Trends Transforming Quality Control
Industrial X-ray Inspection Systems Market Advanced Imaging, Automation, and Eme …
The industrial X-ray inspection systems market is experiencing significant growth, driven by the increasing need for non-destructive testing, quality assurance, and process optimization across diverse industries. Industrial X-ray inspection systems are critical tools for detecting internal defects, structural inconsistencies, and product anomalies without damaging the components being tested. The global Industrial X-ray Inspection Systems Market size is likely to be valued at US$ 1.9 Bn by 2025, and estimated to
U.S. Intrathecal Drugs Market Forecasted to Expand from US$1.7 Billion to US$2.2 Billion by 2032
U.S. Intrathecal Drugs Market Forecasted to Expand from US$1.7 Billion to US$2.2 …
The U.S. intrathecal drugs market is poised for steady growth, with its value projected to rise from US$1.7 billion in 2025 to approximately US$2.2 billion by 2032. This reflects a compound annual growth rate (CAGR) of 3.8% during the forecast period of 2025-2032, underlining the expanding role of intrathecal therapies in pain management and spasticity treatment across the nation. Historical trends from 2019 to 2024 indicate consistent market expansion, fueled

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the